HCC
Hirtle Callaghan & Co’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-88
| Closed | -$28K | – | 159 |
|
|
2017
Q3 | $28K | Hold |
88
| – | – | ﹤0.01% | 126 |
|
|
2017
Q2 | $24K | Sell |
88
-22
| -20% | -$6K | ﹤0.01% | 115 |
|
|
2017
Q1 | $30K | Sell |
110
-600
| -85% | -$164K | ﹤0.01% | 116 |
|
|
2016
Q4 | $202K | Sell |
710
-77
| -10% | -$21.9K | 0.04% | 23 |
|
|
2016
Q3 | $246K | Hold |
787
| – | – | 0.05% | 81 |
|
|
2016
Q2 | $190K | Sell |
787
-40
| -5% | -$9.66K | 0.04% | 82 |
|
|
2016
Q1 | $214K | Sell |
827
-60
| -7% | -$15.5K | 0.04% | 87 |
|
|
2015
Q4 | $272K | Hold |
887
| – | – | 0.06% | 35 |
|
|
2015
Q3 | $259K | Hold |
887
| – | – | 0.04% | 50 |
|
|
2015
Q2 | $358K | Buy |
+887
| New | +$358K | 0.12% | 42 |
|
|
2013
Q4 | – | Sell |
-467
| Closed | -$112K | – | 621 |
|
|
2013
Q3 | $112K | Buy |
+467
| New | +$112K | 0.02% | 273 |
|